Daniel Ré
92 works · 4,051 citations · h-index 29
Top works
- Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
- Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
- Autoimmune haemolytic anaemia associated with COVID‐19 infection
- BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
- Somatic Mutation of the Cd95 Gene in Human B Cells as a Side-Effect of the Germinal Center Reaction
- Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease
- Part I: Hodgkin's lymphoma—molecular biology of Hodgkin and Reed-Sternberg cells
- Part II: Hodgkin's lymphoma—diagnosis and treatment
- Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
- From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
- 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
- Molecular Pathogenesis of Hodgkin's Lymphoma
- Epidemiology and etiology of Hodgkin's lymphoma
- Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells.
- Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy
- Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells
- Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
- Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients
- Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
- Cultivated H-RS cells are resistant to CD95L-mediated apoptosis despite expression of wild-type CD95